|
LDE225
|
Gemcitabine, Nab-paclitaxel
|
Locally Advanced or Metastasized Pancreatic Cancer
|
I/II
|
Unknown
| |
NCT02358161
|
|
EN3835
|
None
|
Uterine Leiomyoma
|
I
|
Completed
|
Enough safety and efficacy, and decreased tumor bulk
|
NCT02889848
|
|
EN3835
|
None
|
Lipoma
|
II
|
Completed
|
dose escalation study
|
NCT01613313
|
|
Losartan
|
Proton beam radiation, FOLFIRINOX
|
Locally Advanced Pancreatic Cancer
|
II
|
Active, not recruiting
| |
NCT01821729
|
|
TRC093
|
None
|
Locally Advanced or Metastatic Solid Tumors
|
I
|
Completed
|
Dose escalation study
|
NCT00492830
|
|
Halofuginone hydrobromide
|
None
|
Human immunodeficiency virus-related Kaposi’s sarcoma
|
II
|
Completed
|
No clear clinical benefits
|
NCT00064142
|
